Hypoxic RBC storage and oxygen handling
A donor RBC experiment in perfused human kidneys, with study-specific findings and limits.
Read the evidence brief ↗Historical HBOC publications, external transplant studies and BHOC research questions have different evidence status.
A donor RBC experiment in perfused human kidneys, with study-specific findings and limits.
Read the evidence brief ↗Historical carrier results are specific to the named product, organ and protocol.
Browse historical records ↗External studies map where organ-specific oxygen questions could be tested.
Browse related evidence ↗A specific carrier needs measured oxygen-release curves, oxidation and stability across cold-to-warm conditions.
Review the science →Time gained, xenograft support and recipient outcomes require separate controlled studies.
Research sequence ↑No source here establishes BHOC transplant efficacy or a clinical indication. Donor, ex-vivo and recipient studies would each need their own evidence and authorization.
The historical catalogue includes a study comparing whole-blood-based perfusate in ex vivo heart perfusion. It is retained as a source route with a single-source review flag. It should not be presented as proof of oxygen-carrier superiority or BHOC heart-preservation efficacy.
A cardiac research protocol needs its own carrier characterization, comparator and myocardial-function endpoints. Findings in kidney or liver perfusion do not establish the same result in the heart.
The related-evidence collection includes an OPTN retrospective analysis of lung transplantation after thoracoabdominal regional perfusion procurement. It is procurement and registry context, not a BHOC or oxygen-carrier intervention study.
Ex vivo lung perfusion, lung-tissue oxygenation and the oxygen-transport behaviour of a perfusate require their own sources and experimental design. They remain separate questions in the BHOC research map.